[Administration of intrapartum erythromycin for the interruption of the vertical transmission of Ureaplasma urealyticum and its possible relation to the development of bronchopulmonary dysplasia in neonates with less than 32 weeks gestation. Multicenter study]

An Esp Pediatr. 1997 Jun:Spec No 1:73-7.
[Article in Spanish]
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study
  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Bronchopulmonary Dysplasia / etiology*
  • Erythromycin / therapeutic use*
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Infectious Disease Transmission, Vertical*
  • Ureaplasma Infections / complications
  • Ureaplasma Infections / prevention & control*
  • Ureaplasma Infections / transmission
  • Ureaplasma urealyticum*

Substances

  • Anti-Bacterial Agents
  • Erythromycin